| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.18 | 0.0004 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0008 |